INTRODUCTION
Inflammatory diseases of the central nervous system (CNS) can be grouped into two broad aetiological categories, which are either infectious or non-infectious (Tipold 1995) . The term "meningoencephalitis of unknown origin" (MUO) is used to describe patients with clinical, MRI and cerebrospinal fluid (CSF) alterations indicating inflammatory non-infectious CNS disease (Zarfoss et al. 2006 , Coates & Jeffery 2014 . MUO thus encompasses all the specific subtypes of non-infectious inflammatory diseases that can be sub-classified by histopathological examination, including: granulomatous meningoencephalomyelitis (GME), necrotising meningoencephalitis (NME), necrotising leukoencephalitis (NLE) (Coates & Jeffery 2014) . In clinical practice CNS biopsies are rarely obtained for cases presenting with clinical signs suggestive of this type of disease and so other means of excluding infectious diseases is required before using immunosuppressive therapies.
It has been estimated that 15% of dogs diagnosed with GME die before treatment (Granger et al. 2010 ) and 56% of dogs diagnosed with MUO die (or are euthanised) following diagnosis, with a median survival time in all deceased dogs of 2 days (range 0 to 52 days) (Lowrie et al. 2013) . Also, about one third of affected dogs can die within the first 72 hours of admission (Lowrie et al. 2013) . Therefore, there is a rationale for more aggressive initial immunosuppressive therapy, which conflicts with the need to rule out infectious aetiologies.
Toxoplasmosis and neosporosis are the two protozoan infectious diseases most commonly suspected of causing disease in the UK and constitute an important part of the differential diagnosis for infectious inflammatory CNS diseases. The prevalence of these diseases has been reported in the UK but not specifically for animals with neurological signs. According to the current literature the prevalence for Neospora caninum antibodies in pet dogs is around 5•8% (Lathe 1994) to 16•6% (Trees et al. 1993) . The serum prevalence of toxoplasmosis in the UK appears only available in unpublished data (12•7%) with a 0% final clinical diagnosis of toxoplasmosis (Hare et al. 2017) . Both parasites have been reported to cause multi-focal CNS disease (Gaitero et al. 2006 , Dubey et al. 2009 ) but their diagnosis can be challenging. MRI findings are non-specific: neosporosis has been reported with multi-focal or focal intra-axial lesions affecting grey and white matter with or without cerebellar involvement and with variable enhancement after contrast administration (Garosi et al. 2010 , Parzefall et al. 2014 ; Suspected toxoplasmosis has been reported in a single report with multi-focal intra-axial hyperintense lesions affecting the cerebrum, periventricular white matter, mesencephalon and metencephalon (Lamb et al. 2005) , although histopathological confirmation was unavailable.
A major difficulty is that dogs can produce antibody titres against these infectious diseases through exposure and without developing clinical disease. An active infection is usually suspected if serum antibody titres increase over several weeks. Little is known of the significance of serological data in the diagnosis of canine neosporosis except that immunoglobulin G (IgG) immunofluorescence antibody test (IFAT) titres are generally ≥1:200 in dogs with confirmed clinical neosporosis. Indirect fluorescent antibody (IFA) titres are generally 1:800 or higher in cases of severe neosporosis. Correlation has not been found between the magnitude of titres and clinical signs (Barber & Trees 1996 , Dubey & Lindsay 1996 , Dubey et al. 1998 , Dubey 2013 . Serologic cross-reactivity between Toxoplasma gondii and N. caninum exists in some assays, but occurrence of cross-reaction is unlikely at titres of 1:50 when using indirect fluorescent antibody test methods (Silva et al. 2007) . A multiplex PCR assay that detects both T. gondii and N. caninum for use with tissues or CSF has been reported (Schatzberg et al. 2003 , Meseck et al. 2005 . Eventually, a positive diagnosis of N. caninum or T. gondii meningoencephalitis can also be reached by identification of the parasite in CSF or tissues (Gaitero et al. 2006) .
The aim of this study was to assess the prevalence of these two infectious diseases in dogs diagnosed and treated for suspected inflammatory meningoencephalitis in the UK.
MATERIALS AND METHODS
A retrospective cohort study was performed reviewing medical records from the Neurology & Neurosurgery units of three referral centres in the North c , Centre b and South a of the UK to identify dogs presented for suspected inflammatory CNS disease. The Veterinary Research Ethics Committee of these institutions approved this study protocol. Inclusion criteria were: dogs with (1) disease localisation to the forebrain, brainstem, cerebellum or brain multi-focal; (2) MRI findings of focal/multi-focal intraaxial lesions compatible with inflammatory diseases; (3) CSF analysis performed when safe for the animal and (4) PCR testing on CSF and/or serology for T. gondii and N. caninum.
The diagnosis of suspected immune-mediated inflammatory or protozoan meningoencephalitis was made when clinical findings and either or both MRI imaging and CSF analysis were abnormal. Clinical evaluation was performed by a European College of Veterinary Neurology (ECVN) diplomate or a supervised ECVN resident. Dogs with normal MRI were included only when CSF contained an increased total nucleated cell count supportive of immune-mediated inflammatory or protozoan meningoencephalitis. Dogs with normal MRI and abnormal cytology results (normal cell count and reactive cells on cytology) and/or albuminocytologic dissociation as the only abnormal CSF finding were excluded. Dogs with MRI characteristics compatible with inflammatory/infectious meningoencephalitis were included in the study in the absence of CSF analysis when performing CSF collection was omitted because of risks associated with imaging findings suggestive of raised intracranial pressure. The latter were included in order to represent the clinical emergency setting of suspected MUO patients.
Diagnostic investigation in all cases included haematology and serum biochemistry profile, N. caninum and T. gondii serology and/ or PCR (on CSF). For neosporosis, an IFA titre >1:50 confirmed exposure to the antigen (Dubey et al. 1988a (Dubey et al. , 1988b (Dubey et al. , 1998 and IFA titres ≥1:800 were considered highly suggestive for active disease (Barber & Trees 1996 , Parzefall et al. 2014 . The IFA method was used for the detection of Immunoglobulin M (IgM) and IgG antibodies specific for T. gondii in serum. An IgG >1:50 confirmed exposure to Toxoplasma. An IgG titre >1:400 or/and an IgM titre >1:64 was considered more consistent with active infection (Costa et al. 1977 , Murphy & Papouliotis 2005 .
MRI was performed in all cases under general anaesthesia using a 1•5 Tesla (T) magnet (Siemens Essenza Magnetom) in institutions C and B and using a 0•4 T (Hitachi Aperto) in the institution A. As a minimum, the following sequences were used: T2-weighted images (T2WI) in three planes, FLAIR (fluidattenuated inversion recovery) and pre-and post-contrast (intravenous injection of 0•1 mmol/kg of gadopentetate dimeglumine) T1-weighted images (T1WI) in transverse planes. One boardcertified neurologist and one board-certified radiologist examined all images and agreed on the diagnosis in each case. Dogs diagnosed with diseases other than inflammatory meningoencephalitis were excluded. Cases in which MRI characteristics and CSF analysis were suggestive of bacterial meningoencephalitis were also excluded for the study.
The CSF collection was performed by either cerebellomedullary cistern (CMC) or lumbar puncture after MRI studies. CSF samples with blood contamination of >5000 RBC/μL were excluded from the study. Results of CSF analysis were considered abnormal if the protein concentration was >30 mg/dL (CMC) or >45 mg/dL (lumbar cistern -LC) or if the nucleated cell count was >5 cells/μL.
The dogs were classified into large and small/medium breed using the criteria reported by Cornelis et al. (2016) . The total
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Descriptive statistics were applied to display proportions of breed, age, gender, neurological examination, imaging findings, CSF analysis, as well as T. gondii and N. caninum testing results. Data were also analysed for normality with a probability plot for normal distribution, and displaying the 95% confidence interval. A one-sample proportion test was then used to compare the proportion of male and female dogs, with statistical significance assumed at P<0•05. All statistical analysis was carried out using statistical software (Minitab 17, Minitab Inc.). To determine an adequate sample size to estimate the population prevalence with a good estimate, calculation was used using a confidence interval of 99% (z=2•58), an expected prevalence (P) of 2% (estimated by our clinical experience) and a precision (d) of 2% and the reported formula n = Z 2 P(1−P)/d 2 (Wayne 1999 , Naing et al. 2006 . Sample size required was 326 dogs to which a 20% number of dogs was added to anticipate missing data, totalling a sample size of 391 dogs (Naing et al. 2006) .
RESULTS
The electronic medical records of the three institutions between 2008 and 2016 were reviewed for dogs diagnosed with inflammatory meningoencephalitis. Four hundred cases met the inclusion criteria (39 from University of Glasgow, 194 from Dick White Referrals and 167 from the University of Liverpool).
Data on the signalment of the dogs is summarised in Table 1 . Further information on the breeds is in the Table S1 , Supporting Information.
Neurological localisation was to the brain "focal" (disease localisation to the forebrain, brainstem, cerebellum) in 145/400 (36•25%; 95%CI: 31•57 to 41•20%) or brain "multifocal" in Fig. 1 . Infectious disease testing (serology and PCR) of the dogs is shown in Fig. 2 (Fig. 3) . Information on the patients positive for toxoplasmosis and neosporosis are summarised in Tables S2 and S3. Only one dog had a serology titre compatible with suspected clinical infection (IgG>400; IgM>800) by T. gondii. This was an 8-year-old bichon frise with a previous history of controlled diabetes mellitus and hyperadrenocorticism and presented for lethargy, circling and left-sided blindness. Neurolocalisation was to the forebrain and MRI of the brain identified multi-focal changes within the forebrain and meninges. CSF analysis was abnormal with elevated TNCC and protein but cytology was unavailable.
(IgG<50 and IgM<20). Pyrimethamine was discontinued and clindamycin was prescribed for a further month. Unfortunately, the dog was then lost to follow-up and it died 18 months later of unrelated reasons.
Conclusion on the definitive diagnosis in this case remains unclear and if this was a false-positive result the prevalence for toxoplasmosis in the cases with diagnosis of suspected MUO in the present study would be close to 0%. The seroprevalence of T. gondii in dogs in this cohort of dogs (3•98%) was lower than recently identified by Hare et al. (2017) of 12•7%. The latter is similar to seroprevalence in other parts of the world (Gao et al. 2016 ).
DISCUSSION
In this study the prevalence of active clinical infection of T. gondii and N. caninum in patients with suspected inflammatory meningoencephalitis in the UK was very low (0•25 and 2•25%, respectively). Evidence for antigenic exposure to these diseases was also uncommon (3•98 and 6•96%, respectively). Because of the comparative rarity of evidence of exposure this study highlights that the risk associated with starting immunosuppressive medication in patients suspected of inflammatory meningoencephalitis (but before diagnostic confirmation of negative evidence for exposure to protozoan infections) in the UK is low. Associated MRI evidence for cerebellar disease should make the clinician suspicious Immunosuppressive therapy with doses of 50 mg/m 2 cytarabine subcutaneously, twice daily, for a total of four injections and 25 mg/kg clindamycin daily were started while infectious disease titres were pending. No clinical decline was reported during that period. Following identification of abnormal T. gondii titres, pyrimethamine was prescribed for 2 months, clindamycin was continued and immunosuppressive treatment discontinued; At 2-month re-examination, only mild proprioceptive deficits in the left pelvic limb and decreased menace response on the left eye were present. At 4 months follow-up, serology was repeated of N. caninum infection and immunosuppression is not recommended until testing results rule it out.
Rational patient selection on clinical presentation alone (i.e. without histopathological confirmation) is a limitation when studying dogs suffering with MUO. Although this evidence base limitation allows for dogs with other disorders (neoplasia, other infectious inflammatory CNS disease) to be incorporated in these studies, previous study guidelines have been consulted to maximise patient recruitment while minimising heterogeneity (Granger et al. 2010 , Coates & Jeffery 2014 . Patients selected for this study were therefore selected based on clinical diagnostic suspicion.
Dogs diagnosed with MUO can be of any age, gender or size. Although, middle-aged female toy and terrier breeds have been reported to be predisposed (Munana & Luttgen 1998 , Adamo et al. 2007 , Talarico & Schatzberg 2010 , in the present study, females were not overrepresented and dogs of all ages were affected. Also, although MUO was identified more often in small/medium breed dogs (60%; 95%CI: 55•00 to 64•81%), 40% (95%CI: 35•19 to 45•00%) of dogs were of large breeds. This emphasises that MUO should still be an important part of the differential diagnosis in medium/large dogs with suspected brain disease (Cornelis et al. 2016) . Similar breeds to those previously reported were identified (Labrador retriever, cocker spaniel, springer spaniel, cross breed etc. Specific details on breeds are available in the Table S1) .
Multiple, single, or diffuse intra-axial hyperintense lesions on T2WI MR images are possible with MUO (Coates & Jeffery 2014) . We found a majority of intra-axial multi-focal lesions in this study. Although breed-specific MRI characteristics of necrotising encephalitis have been published in an attempt to establish a clinical diagnosis with a relatively high degree of certainty (Flegel 2017) , no MRI characteristics are considered specific for the diagnosis of MUO. In accordance with other studies, FLAIR and T2WI sequences were the most useful in identifying multi-focal brain lesions with a presumptive diagnosis of inflammatory CNS diseases (Cherubini et al. 2006) . The degree of contrast enhancement on T1W images is also a non-specific finding associated with many CNS disorders and should not be used as an indicator for presence or absence of disease (Lamb et al. 2005) . Histopathological involvement of the cerebellum has been reported with NME and GME but can also be seen with neosporosis. The latter has been reported to be associated with necrotising cerebellitis and cerebellar atrophy (Garosi et al. 2010) , as well as with multifocal brain lesions (Parzefall et al. 2014) . Cerebellar lesions were identified in five out of nine dogs diagnosed with suspected neosporosis. In dogs where neosporosis is suspected based on MRI and serology, identification of other factors such as elevated creatine kinase, proximity to livestock, maternal neosporosis infection, infection of siblings would strengthen the suspicion. MRI features of suspected T. gondii encephalitis are not so well documented and have only been described in one dog (Lamb et al. 2005) . In cats, this protozoan is known to cause focal granuloma formation in both the forebrain (Pfohl & Dewey 2005 , Falzone et al. 2008 ) and the spinal cord (Alves et al. 2011) . Differential diagnoses for multi-focal intracranial lesions would include inflammatory meningoencephalitis, neoplasia (lymphoma, gliomatosis cerebri, metastatic disease), metabolic, degenerative and cerebrovascular disorders (Cherubini et al., 2005 , Wolff et al., 2012 Bentley et al., 2014) . A normal MRI examination does not rule out CNS inflammatory disease (Lamb et al. 2005) .
CSF analysis is highly variable in the different types of MUO but little difference exists between these groups. Mononuclear pleocytosis with elevated protein concentration are typical CSF analysis findings in MUO patients and were common features in the present study. Cytological changes must always be interpreted in light of each patient's history and neurological findings. Abnormal CSF findings always indicate a pathological abnormality if blood contamination has been ruled out (Terlizzi & Platt 2009 ). However, normal CSF was also identified in dogs with abnormal clinical and imaging findings, similarly to previous reports (Tipold 1995 , Cherubini et al. 2006 , Granger et al. 2010 , Flegel 2017 . A variety of CSF findings (moderate lymphocytic, neutrophilic or mixed cells pleocytosis) have been reported with GME (Chrisman 1992 , Munana & Luttgen 1998 , Terlizzi & Platt 2009 ). Marked lymphoid pleocytosis has been seen in some animals with CNS lymphoma (Long et al. 2001 ) and lymphoblasts can also be identified (Freeman & Raskin 2001 , Long et al. 2001 . Also, well-differentiated lymphoid malignancies might not be easily differentiated from a lymphocytic pleocytosis (Freeman & Raskin 2001) . Therefore, possible inclusion of cases with lymphoma, gliomatosis cerebri or cerebrovascular disease is another study limitation. Diagnostic methods for lymphoma were not performed in these patients (cytopathology, histopathology, immunophenotyping, PARR, VDI TK canine+, canine lymphoma blood test) (Schleis 2014) .
Serology is the principal method of N. caninum diagnosis but is an indirect diagnostic test and can be negative in early or chronic infection (Ghalmi et al. 2008) . Reports of the sensitivity and specificity of IFAT in dogs to demonstrate antibodies to N. caninum could not be identified and, although it is often used as a reference test (indicator of true status) because it shows little cross-reactivity with other coccidian parasites, the divergence in test performance between laboratories can make direct comparison of IFAT titres difficult (Bjorkman & Uggla 1999) . In the present study, serology on blood was more sensitive for detection of this pathogen than PCR on CSF. Serology identified 14 cases out of 201, whereas only two cases out of 211 were positive on CSF. In one case (Case 3) a serology titre of 1:800 was obtained but PCR on CSF was negative. This can indicate that either the PCR sensitivity was too low or that the parasite was not present in CSF. PCR for N. caninum on liver and spleen of dogs has also been reported to be less sensitive then IFAT, but the major advantage on PCR is that it offers an alternative to histological methods for the detection of N. caninum (Ghalmi et al. 2008) . The seroprevalence of N.caninum identified in this cohort of dogs (6•9%) is similar to previous data reported in the general population of dogs in the U.K 5•8 to 16% (Trees et al. 1993 , Lathe 1994 . We therefore consider that serology testing should be performed as primary approach because of its higher sensitivity, but PCR on CSF or serial serology demonstrating rising titres should be obtained to confirm the diagnosis. PCR offers a more specific means of documenting active infection by amplify- ing N. caninum-specific deoxyribonucleic acid in CSF (or body fluid/tissue biopsy), but it has to be present to be amplified and therefore false negatives are possible if the protozoan is embedded deeper in tissues (Schatzberg et al. 2003) .
Historically, canine toxoplasmosis is considered an opportunistic infection, and clinical signs are not expected to occur unless there is a compromised immune system (Dubey & Odening 2001; Mineo et al. 2001; Dubey et al. 2006 , Gerhold et al. 2014 . However, nonimmunocompromised dogs have also been reported to be infected (Tarlow et al. 2005) . IFAT is a simple test detecting both IgG and IgM antibodies and it has been widely used in human and animals with sensitivities (80 to 100%) and specificities (91 to 95%) reported in human and sheep (Shaapan et al. 2008 , dos Santos et al. 2010 . The pattern of canine T. gondii antibody production and persistence is still being studied. In dogs experimentally inoculated with T. gondii, IgM antibodies were detected using enzyme-linked immunosorbent assay 7 days following inoculation and IgM levels decreased around day 27. This study also detected IgG antibodies as early as day 7 (Silva et al. 2002) . The case series reported by Tarlow et al. (2005) suggests that infection in dogs might produce more transient IgM titre elevations than in cats or that the signs of infection develop weeks after exposure/IgM production or that the animals reported had chronic T. gondii infections for which they acutely become clinical.
Supporting Information
The following supporting information is available for this article: Table S1 . Breeds of dogs classified based on their body size (large versus small medium). Table S2 . Positive (+) cases for T. gondii. Table S3 . Positive (+) cases for N. caninum.
